Zoetis | ZTS - Current Liabilities


Zoetis reported $2.06B in Current Liabilities for its fiscal quarter ending in June of 2026.





Current Liabilities Change Date
AbbVie USD 41.64B 458M Jun/2026
Align Technology USD 1.91B 2.74M Jun/2026
Bayer EUR 32.27B 1.19B Jun/2026
Bristol-Myers Squibb USD 18.66B 499M Jun/2026
Charles River Laboratories USD 1.13B 41.04M Jun/2026
Coherus Biosciences USD 75.51M 56.82M Jun/2026
Dentsply International USD 1.18B 22M Jun/2026
Eli Lilly USD 47.74B 11.11B Jun/2026
Henry Schein USD 3.49B 191M Jun/2026
Idexx Laboratories USD 1.29B 12.19M Jun/2026
Illumina USD 1.58B 12M Jun/2026
IQVIA Holdings USD 8.82B 486M Jun/2026
J&J USD 54.9B 2.82B Jun/2026
Laboratory Of America USD 2.12B 516.4M Jun/2026
Merck USD 27.73B 786M Jun/2026
Neogen USD 158.2M 7.6M Mar/2026
Pacira USD 122.01M 13.22M Jun/2026
Perrigo USD 1.05B 57.2M Jun/2026
Pfizer USD 32.65B 1.7B Jun/2026
Phibro Animal Health USD 281.87M 500K Mar/2026
Quest Diagnostics USD 1.79B 389M Jun/2026
Sanofi EUR 31.93B 1.92B Jun/2026
Sanofi EUR 30.01B 1.66B Mar/2026
Zoetis USD 2.06B 8M Jun/2026